T. Rowe Price Associates’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$455M Buy
10,673,661
+11,425
+0.1% +$460K 0.05% 265
2025
Q4
$399M Buy
10,662,236
+478,436
+5% +$16M 0.04% 298
2025
Q3
$301M Buy
10,183,800
+7,059,722
+226% +$164M 0.03% 360
2025
Q2
$73.7M Buy
3,124,078
+603,858
+24% +$12.6M 0.01% 635
2025
Q1
$45.6M Sell
2,520,220
-178,409
-7% -$3.5M 0.01% 749
2024
Q4
$46M Buy
2,698,629
+328,977
+14% +$5.69M 0.01% 780
2024
Q3
$34.8M Buy
2,369,652
+857,471
+57% +$10.7M ﹤0.01% 854
2024
Q2
$17.2M Buy
1,512,181
+16,457
+1% +$180K ﹤0.01% 990
2024
Q1
$16.3M Buy
+1,495,724
New +$15M ﹤0.01% 1027

Other funds holding BTSG

T. Rowe Price Associates's BTSG Position: Q1 2026 in Review

T. Rowe Price Associates increased its BrightSpring Health Services (BTSG) stake by 0.11% in Q1 2026, buying an estimated $460K and bringing the position to 10,673,661 shares worth $455M. The position accounts for 0.05% of the portfolio, ranked #265.

T. Rowe Price Associates first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • T. Rowe Price Associates held 10,673,661 shares of BrightSpring Health Services worth $455M as of Q1 2026.
  • T. Rowe Price Associates bought 11,425 BrightSpring Health Services shares in Q1 2026, an estimated $460K.
  • BrightSpring Health Services made up 0.05% of T. Rowe Price Associates's portfolio in Q1 2026, its #265 holding.
  • T. Rowe Price Associates first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.